MARA 20-day bearish forecast — Nov 15, 2026
- Bias: Bearish
- Timeframe: 20 days (made Nov 15, 2026, target date Dec 4, 2026)
- Price at analysis: $6.99
- Price target: $6.50
- Expected range: $5.70 – $7.60
- Result: Pending — graded after the close on Dec 4, 2026
Get a free AI analysis of MARA today
Analysis
TECHNICAL INDICATORS
- RSI (14): 42.50, recovering from the oversold low of 23.5 on Oct 26 and peaking at 47.9 on Nov 11 before rolling over slightly. It is still below 50 and has made a series of higher lows. Momentum has improved but has not turned bullish. [Neutral]
- 20 EMA: The 21 EMA is $7.47 and price at $6.99 is below it, so it acts as resistance. The EMA is still falling (from $8.92 on Oct 26), and the EMA21 is far below the EMA55 ($8.93). [Bearish]
- MACD: The line is -0.643 and the signal is -0.846, so the line is above the signal (a bullish crossover around Nov 3). The histogram is positive and rising, but both lines remain below zero. This is a bullish momentum shift inside a larger downtrend. [Bullish]
- Bollinger Bands (20): Upper $7.93, lower $6.13, so price is in the lower half of the bands, about 45% of the way from the lower band to the upper. The bands are starting to contract after the heavy selloff. Price touched the lower band on Nov 5 ($5.88) and bounced. There is no active squeeze or breakout. [Neutral]
- CMF (20): 0.048, just under the +0.05 accumulation threshold. It has risen from -0.352 on Oct 26 and is now hovering near zero or slightly positive. Selling pressure has faded and buying pressure is building. [Neutral]
- ADX (14): 32.8, a strong trend, but it is falling from a peak of 38.9. −DI (32.0) is above +DI (20.6), so the bears still control the trend. The gap has narrowed from the peak (−DI 38.4 vs +DI 11.9). [Strong Trend – Bearish, weakening]
- Volume: 42.33M, in line with recent averages. The Nov 10 rally came on elevated volume (a larger green bar), which suggests some real buying interest. There is no capitulation spike. [Neutral to mildly Bullish]
DIVERGENCES & TRENDS
- Bullish divergence: The Nov 5 low at $5.88 was well below the Oct 26 close at $6.84, yet RSI was higher (28.1 vs 23.5). MACD has also made higher lows. Together these show waning downside momentum.
- MACD: It crossed above the signal line with a rising histogram, but it is still below zero. That makes it a relief-rally signal, not a confirmed trend reversal.
- CMF: It has moved from -0.35 to about +0.05, which is a clear improvement in money flow. This is the strongest bullish sign on the chart.
- Moving averages: Price is below every moving average: EMA21 ($7.47), EMA55 ($8.93), SMA50D ($9.52), SMA200D ($10.62) and VWAP ($10.40). The SMA50D is below the SMA200D (death cross already in place), and both are still declining. The long-term structure remains bearish.
- ADX/DI: ADX is rolling over and the DI gap is narrowing, which points to a decelerating downtrend, but there is no bullish DI crossover yet.
- Price action: Since Nov 5 price has made a higher low and recovered to $7.66 (just above EMA21), but it was rejected there and is now back at $6.99 with lower highs inside the Bollinger Bands.
CHART PATTERNS
- Bearish Flag/Pennant-like consolidation: Since the October plunge, price has traded sideways in a roughly $5.88–$7.66 range after a sharp drop. If it breaks down, the measured move points toward $5.50 or lower.
- Possible Bullish Double Bottom: The lows at ~$6.43 (Nov 2) and $5.88 (Nov 5), with a neckline around $7.66, form a rough base. A close above $7.66 would target about $9.40 (a measured move of ~$1.78), but the pattern is not confirmed.
- Context: The prevailing trend is down. The sequence of lower highs and lower lows is intact, and the death cross is in place. The reversal pattern needs a neckline breakout with volume before it can be trusted.
POTENTIAL SCENARIOS
- Scenario 1: Bearish Trend Resumption — Price fails at EMA21 ($7.47) again and the downtrend continues, with −DI still dominant and ADX above 25. The relief rally stalls below all major moving averages. Trigger: Daily close below $6.40, then below the Nov 5 low of $5.88. Target: $5.90–$6.10, with extension to $5.50. Invalidation: Daily close above $7.70. (45% probability)
- Scenario 2: Bullish Relief Rally / Base Breakout — Bullish MACD, rising CMF and RSI divergence support a push toward the upper Bollinger Band and the double-bottom neckline. Trigger: Close above $7.66 on rising volume. Target: $8.40–$8.90 (EMA55 area). Invalidation: Close below $6.13. (30% probability)
- Scenario 3: Neutral Range Consolidation — Price chops between support near $6.10 and resistance near $7.60 as the bands contract and ADX fades. Trigger: Failure to break either side of the range. Target: $6.70–$7.30. Invalidation: Close outside $5.90–$7.80. (25% probability)
PRICE TARGETS
For the 20-day timeframe (target date Dec 5, 2026), I weigh the following:
- Bearish: the long-term structure is bearish, −DI is above +DI, and price is below every moving average.
- Bullish: MACD has crossed, CMF is improving and RSI shows divergence.
- The bearish structure carries slightly more weight, but the bounce momentum limits the downside, so I project a modest decline.
Range width check: $5.95 to $7.95 = $2.00, which is 28.6% of the current price. That is too wide for a 20-day horizon (guide ~8–12% for 14–21 days, which would be about $0.56–$0.84 wide). However, MARA's ATR of $0.68 (about 9.7% of price per day) implies far higher volatility than a typical stock, so I use a range of ~$1.70 (24%), at the upper end but justified by the ATR, which exceeds the guide. The range is wider than any 2–3 day range, as required.
- Target Price: $6.50 (below the current price of $6.99)
- Expected Range: $5.70 to $7.60
- Key Levels: Support at $5.88, Resistance at $7.47
OVERALL BIAS
OVERALL BIAS: BEARISH - Price is below all major moving averages with −DI above +DI and ADX above 30. The death cross remains in place, and the bounce keeps stalling at the EMA21 resistance. The improving MACD, CMF and RSI divergence argue for a choppy path, but they have not yet broken the downtrend.
This is educational analysis and not financial advice.